International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite severe hyperlipidemia, GSD Ia patients show limited atherogenesis compared to age-and-gender matched controls. Employing a GSD Ia mouse model that resembles the severe hyperlipidemia in patients, we here found increased atherogenesis in GSD Ia. These data provide a rationale for investigating atherogenesis in GSD Ia in a larger patient cohort
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
AbstractGlycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile ...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
International audienceGlycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate m...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
AbstractGlycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile ...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...